SCHEMBL26265451

SCHEMBL26265451

COC(=O)c1cc(N)ccc1OI

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 7/20 0.57
KDM4E B2RXH2 5/20 0.46
ALDH1A1 P00352 6/20 0.45
MAPT P10636 4/20 0.45
HSD17B10 Q99714 3/20 0.45
HPGD P15428 3/20 0.45
GLA P06280 2/20 0.45
CASP1 P29466 1/20 0.45
CASP7 P55210 1/20 0.45
ATM Q13315 1/20 0.45
CFTR P13569 3/20 0.44
ABL1 P00519 1/20 0.44
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
POLB P06746 1/20 0.42
ALOX5 P09917 1/20 0.41
MAPK1 P28482 1/20 0.41
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL570110 0.86 GAA (0.61) GAAKDM4EALDH1A1MAPTHSD17B10
Hydrochloric Acid SCHEMBL15488205 0.84 GAA (0.59) GAAKDM4EALDH1A1MAPTHSD17B10
Hydrochloric Acid SCHEMBL7564049 0.84 GAA (0.59) GAAKDM4EALDH1A1MAPTHSD17B10
SCHEMBL5317567 0.81 GAA (0.56) GAAKDM4EALDH1A1MAPTHSD17B10
SCHEMBL24074336 0.80 ALDH1A1 (0.56) GAAKDM4EALDH1A1MAPTHSD17B10
SCHEMBL7564303 0.80 GAA (0.54) GAAKDM4EALDH1A1MAPTHSD17B10
SCHEMBL31604216 0.80 GAA (0.54) GAAKDM4EALDH1A1MAPTHSD17B10
SCHEMBL16550077 0.80 GAA (0.54) GAAKDM4EALDH1A1MAPTHSD17B10
SCHEMBL1403643 0.80 GAA (0.72) GAAKDM4EALDH1A1MAPTHSD17B10
SCHEMBL654962 0.79 GAA (0.53) GAAKDM4EALDH1A1MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230399322-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-12-14 US disclosed
US-11753403-B2 EIF4E inhibitors and uses thereof PIC Therapeutics, Inc. (US) 2023-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230399322-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 GAA 2552/4885KDM4E 710/4885ALDH1A1 4776/4885
US-11753403-B2 EIF4E inhibitors and uses thereof EIF4E, EIF4EBP1, EIF4A1 GAA 2552/4885KDM4E 710/4885ALDH1A1 4776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.